@article{934db325b8204f6cb499461c25133b91,
title = "Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report",
keywords = "Oncocytoma, Pazopanib, Renal preservation",
author = "Matthew Labriola and Foo, {Wen Chi} and George, {Daniel J.} and Tian Zhang",
note = "Funding Information: Dr George discloses research funding from Exelixis, Genentech, Janssen, Novartis, Pfizer, Viamet Pharmaceuticals, Astellas Pharma, Bristol-Myers Squibb, Millennium, Acerta Pharma, Bayer, GlaxoSmithKline, Dendreon, AstraZeneca, and Sanofi; consultant/advisory roles from Bayer, Dendreon, Exelixis, Medivation, Novartis, Pfizer, Sanofi, GSK, Astellas Pharma, Innocrin Pharma, Bristol Myers Squibb, Genentech, Janssen, Acceleron Pharma, Celgene, Merck Sharp & Dohme, and Myovant Sciences; and speakers' bureau for Dendreon, Novartis, Sanofi, and Bayer. Dr Zhang discloses research funding from Janssen, Pfizer, Acerta Pharma, Novartis, Regeneron, and Stemcentrx; consultant/advisory roles for Janssen, Bayer, Genentech, Sanofi, and Exelixis; and ownership/employment (spouse) in Capio BioSciences. The remaining authors haved stated that they have no conflicts of interest. ",
year = "2018",
month = jun,
doi = "10.1016/j.clgc.2018.02.017",
language = "English (US)",
volume = "16",
pages = "e509--e512",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",
}